Novozymes A/S (NVZMF) Stock

About Novozymes A/S

Novozymes A/S, a Danish enterprise established in 1925 and headquartered in Bagsvaerd, is a leading provider of biological solutions, specializing in the production and global distribution of industrial enzymes, microorganisms, and probiotics. Its extensive reach spans across Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company's diverse portfolio caters to a wide array of sectors, including the food and beverage industry with innovations for baking, beverages, dairy, starch processing, and protein applications. In household care, its products enhance laundry, dishwashing, and professional cleaning. For agriculture, Novozymes supports crop production with bioyield and biocontrol technologies, alongside animal health and nutrition solutions. It also contributes to industrial processing, providing solutions for grain and technical processes, as well as bioenergy applications encompassing liquefaction, saccharification, fermentation, and the conversion of fiber and biomass. Other significant areas of focus include textile treatments (such as biopreparation, biopolishing, and denim finishing), pulp and paper production (enhancing fiber modification, bleach boosting, and deinking), and leather processing (from soaking and bating to unhairing and degreasing). Furthermore, its expertise extends to water and waste management with bioaugmentation, biogas, and sludge control technologies. Additionally, Novozymes plays a role in pharmaceuticals, offering lipases and proteases for biocatalysis and rTrypsin for cell culture, in addition to broader human health and protein-related solutions.

Novozymes A/S is headquartered in DK.

Novozymes A/S (NVZMF) stock trades at $66.00 with a market capitalization of $30.77B. The stock is valued at a price-to-earnings (P/E) ratio of 42.66, price-to-book of 2.40, price-to-sales of 6.25. Over the past 52 weeks the stock has ranged between $52.10 and $67.50, and currently trades 2.2% below its 52-week high. It pays a dividend yielding 2.00%.

On profitability, Novozymes A/S generates a return on equity (ROE) of 5.52%, return on capital employed of 5.72%, an operating margin of 20.85%, a net profit margin of 14.21%.

In its most recent fiscal year, Novozymes A/S reported annual revenue of $4.2B, net profit of $584.0M, revenue has compounded at -21.6% a year over the last five years, profit at -27.0% a year.

The balance sheet shows a debt-to-equity ratio of 0.29 — a conservative balance sheet with little leverage risk, a current ratio of 1.67, total assets of $16.3B, $275.0M in cash and equivalents.

NVZMF has an average daily trading volume of 1,472 shares, a beta of 0.62 (less volatile than the overall market).

Official website: www.novonesis.com